|
1.
|
2024/06/18
|
|
Prognostic factors for gastric cancer patients aged ≥ 85 years
|
|
2.
|
2023/12
|
|
Optimization of decellularization methods using human small intestinal submucosa for scaffold generation in regenerative medicine
|
|
3.
|
2023/08
|
|
Proximal resection line determination using intraoperative radiography in laparoscopic distal gastrectomy for gastric cancer
|
|
4.
|
2023/07
|
|
End sigmoid colostomy reconstruction using purse-string subcutaneous suture via extraperitoneal route at the site of a previous transperitoneal loop stoma
|
|
5.
|
2023/07
|
|
Poor prognosis in patients with stage III colorectal cancer receiving adjuvant FOLFOX/CAPOX therapy is predicted by the presence of many poorly differentiated clusters
|
|
6.
|
2023/05
|
|
The comparison of prognoses between total and distal gastrectomy for gastric cancer in elderly patients ≥ 80 years old.
|
|
7.
|
2023/05
|
|
The suppressive effect of NF-kB activation after eicosapentaenoic acid intake before surgery
|
|
8.
|
2023/04
|
|
The prognostic significance of preoperative nutritional/inflammatory markers and clinicopathological features in resectable esophagectomy patients: possibility of nutritional intervention
|
|
9.
|
2022/12
|
|
Is D2 Lymphadenectomy Necessary in Elderly Gastric Cancer Patients? A Retrospective Study
|
|
10.
|
2022/11/24
|
|
The comparison of prognoses between total and distal gastrectomy for gastric cancer in elderly patients≥80 years old
|
|
11.
|
2022/08
|
|
Neoadjuvant docetaxel, oxaliplatin and S‑1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi‑center, phase II study
|
|
12.
|
2022/04
|
|
Three-year outcomes of a phase II study of perioperative capecitabine plus oxaliplatin therapy for clinical SS/SE N1-3 M0 gastric cancer (OGSG 1601)
|
|
13.
|
2022/02
|
|
Prospective multicenter interventional study of surgical resection for liver metastasis from gastric cancer: R0 resection rate, and operative morbidity and mortality
|
|
14.
|
2022/01/07
|
|
Prognostic factors for elderly gastric cancer patients who underwent gastrectomy
|
|
15.
|
2022/01/07
|
|
Prognostic factors for elderly gastric cancer patients who underwent gastrectomy
|
|
16.
|
2022/01
|
|
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study
|
|
17.
|
2022/01
|
|
Survival analyses of elderly gastric cancer patients with or without surgery
|
|
18.
|
2021/09
|
|
Coexisting primary tumors from esophageal cancer and myelodysplastic syndromes: A case report
|
|
19.
|
2021/09
|
|
Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201
|
|
20.
|
2021/09
|
|
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
|
|
21.
|
2021/08
|
|
Intramural hematoma of the descending colon with intraperitoneal hemorrhage: a case report
|
|
22.
|
2021/07
|
|
Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S-1 chemotherapy after gastrectomy: A multicenter, open-label, single-arm, prospective phase II study (OGSG1108)
|
|
23.
|
2021/06
|
|
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study
|
|
24.
|
2021/05
|
|
Prognostic factors for cytology‑positive gastric cancer: a multicenter retrospective analysis
|
|
25.
|
2021/04
|
|
Perioperative predictive markers for recurrence of esophageal cancer after esophagectomy
|
|
26.
|
2020/10
|
|
Is it Necessary to Confirm Negative Margins in Gastrectomy for Peritoneal Lavage Cytology-positive Gastric Cancer?
|
|
27.
|
2020/10
|
|
Simultaneous triple cancer of the esophagus, pancreas and rectum treated with multimodal strategies: a case report.
|
|
28.
|
2020/10
|
|
Successful treatment of gastric cancer after complete response of lung cancer by nivolumab: a case report
|
|
29.
|
2020/09
|
|
Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials.
|
|
30.
|
2020/08
|
|
Bridge to surgery using a self-expandable metallic stent for stages II-III obstructive colorectal cancer.
|
|
31.
|
2020/07
|
|
A Case of Giant Gastrointestinal Stromal Tumor of the Jejunum in the Kingdom of Cambodia
|
|
32.
|
2020/04
|
|
Prognostic Factors for Para-aortic Lymph Node Dissection After Neoadjuvant Chemotherapy for Gastric Cancer.
|
|
33.
|
2020/02
|
|
A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).
|
|
34.
|
2019/11
|
|
Is D2 Lymphadenectomy Essential for Cytology-positive Gastric Cancer? A Retrospective Analysis.
|
|
35.
|
2019/02
|
|
Trastuzumab With S-1 Plus Cisplatin in HER2-positive Advanced Gastric Cancer Without Measurable Lesions: OGSG 1202.
|
|
36.
|
2019/01
|
|
Prognostic factors for cytology-positive gastric cancer.
|
|
37.
|
2018/12
|
|
Randomized, Open-Label Phase II Study Comparing Capecitabine-Cisplatin Every 3 Weeks with S-1-Cisplatin Every 5 Weeks in Chemotherapy-Naïve Patients with HER2-Negative Advanced Gastric Cancer: OGSG1105, HERBIS-4A Trial.
|
|
38.
|
2018/05
|
|
A Case of Corrosive Esophagitis in Lao People's Democratic Republic
|
|
39.
|
2018/05
|
|
Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer?
|
|
40.
|
2017/04
|
|
Survival benefit of gastrectomy for gastric cancer in patients ≥85 years old: A retrospective propensity score-matched analysis.
|
|
41.
|
2016/10
|
|
Prognostic Factors of Oral Intake After Endoscopic Gastroduodenal Stent Placement for Advanced Gastric Cancer.
|
|
42.
|
2016/04
|
|
Risk factors for superficial incisional surgical site infection after gastrectomy: analysis of patients enrolled in a prospective randomized trial comparing skin closure methods.
|
|
43.
|
2015/02
|
|
Our experience of treating undifferentiated gastric carcinoma: report of four cases.
|
|
44.
|
2014/03
|
|
Efficacy of endoscopic gastroduodenal stenting for gastric outlet obstruction due to unresectable advanced gastric cancer: a prospective multicenter study.
|
|
45.
|
2014/03
|
|
Prognostic factors for gastrectomy in elderly patients.
|
|
46.
|
2013/12
|
|
Prognosis of gastric carcinoma patients aged 85 years or older who underwent surgery or who received best supportive care only.
|
|
47.
|
2013/09
|
|
Subcuticular sutures versus staples for skin closure after open gastrointestinal surgery: a phase 3, multicentre, open-label, randomised controlled trial.
|
|
48.
|
2012/10
|
|
Gastric neuroendocrine tumors in our institutions according to the WHO 2010 classification.
|
|
49.
|
2011/06
|
|
Treatment for gastric carcinoma in the oldest old patients.
|
|
50.
|
2009/10
|
|
Laparoscopic Heller-Dor surgery for esophageal achalasia: impact of intraoperative real-time manometric feedback on postoperative outcomes.
|
|
51.
|
2009/02
|
|
Effect of rikkunshito, a chinese herbal medicine, on stasis in patients after pylorus-preserving gastrectomy.
|
|
52.
|
2007/01
|
|
A simple application technique of fibrin-coated collagen fleece (TachoComb) in laparoscopic surgery.
|
|
53.
|
2006/07
|
|
Dai-kenchu-to, a Chinese herbal medicine, improves stasis of patients with total gastrectomy and jejunal pouch interposition.
|
|
54.
|
2006/04
|
|
Motility of the pouch correlates with quality of life after total gastrectomy.
|
|
55.
|
2004/02
|
|
Laparoscopic intragastric resection of gastric stromal tumor located at the esophago-cardiac junction.
|
|
56.
|
2001/04
|
|
A new method of laparoscopic cholecystectomy using three trocars combined with suture retraction of gallbladder
|
|
Display 5 items
|
|
Display all(56)
|
